-
1
-
-
0034662320
-
Association of menstrual and reproductive factors with breast cancer risk: Results from the Shanghai Breast Cancer Study
-
Gao YT, Shu XO, Dai Q, Potter JD, Brinton LA, Wen W, et al. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer 2000;87:295-300.
-
(2000)
Int J Cancer
, vol.87
, pp. 295-300
-
-
Gao, Y.T.1
Shu, X.O.2
Dai, Q.3
Potter, J.D.4
Brinton, L.A.5
Wen, W.6
-
2
-
-
0035030368
-
Breast cancer genetics: What we know and what we need
-
Nathanson KL, Wooster R, Weber BL. Breast cancer genetics: what we know and what we need. Nat Med 2001;7:552-6.
-
(2001)
Nat Med
, vol.7
, pp. 552-556
-
-
Nathanson, K.L.1
Wooster, R.2
Weber, B.L.3
-
3
-
-
0028272001
-
Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins
-
Gonzalez FJ, Gelboin HV. Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metab Rev 1994;26:165-83.
-
(1994)
Drug Metab Rev
, vol.26
, pp. 165-183
-
-
Gonzalez, F.J.1
Gelboin, H.V.2
-
4
-
-
0032749945
-
A systematic review of genetic polymorphisms and breast cancer risk
-
Dunning AM, Healey CS, Pharoah PD, Teare MD, Ponder BA, Easton DF. A systematic review of genetic polymorphisms and breast cancer risk. Cancer Epidemiol Biomarkers Prev 1999;8:843-54.
-
(1999)
Cancer Epidemiol Biomarkers Prev
, vol.8
, pp. 843-854
-
-
Dunning, A.M.1
Healey, C.S.2
Pharoah, P.D.3
Teare, M.D.4
Ponder, B.A.5
Easton, D.F.6
-
5
-
-
0025037307
-
Cytochrome P450dbl phenotypes in malignant and benign breast disease
-
Pontin JE, Hamed H, Fentiman IS, Idle JR. Cytochrome P450dbl phenotypes in malignant and benign breast disease. Eur J Cancer 1990;26:790-2.
-
(1990)
Eur J Cancer
, vol.26
, pp. 790-792
-
-
Pontin, J.E.1
Hamed, H.2
Fentiman, I.S.3
Idle, J.R.4
-
6
-
-
0026092344
-
Polymorphic oxidation of debrisoquine in women with breast cancer
-
Ladero JM, Benitez J, Jara C, Llerena A, Valdivielso MJ, Munoz JJ, et al. Polymorphic oxidation of debrisoquine in women with breast cancer. Oncology 1991;48:107-10.
-
(1991)
Oncology
, vol.48
, pp. 107-110
-
-
Ladero, J.M.1
Benitez, J.2
Jara, C.3
Llerena, A.4
Valdivielso, M.J.5
Munoz, J.J.6
-
7
-
-
0025761626
-
Metabolism of debrisoquine and susceptibility to breast cancer
-
Huober J, Bertram B, Petru E, Kaufmann M, Schmahl D. Metabolism of debrisoquine and susceptibility to breast cancer. Breast Cancer Res Treat 1991;18:43-8.
-
(1991)
Breast Cancer Res Treat
, vol.18
, pp. 43-48
-
-
Huober, J.1
Bertram, B.2
Petru, E.3
Kaufmann, M.4
Schmahl, D.5
-
8
-
-
0030044515
-
CYP2D6 genotypes in Spanish women with breast cancer
-
Ladona MG, Abildua RE, Ladero JM, Roman JM, Plaza MA, Agundez JA, et al. CYP2D6 genotypes in Spanish women with breast cancer. Cancer Lett 1996;99:23-8.
-
(1996)
Cancer Lett
, vol.99
, pp. 23-28
-
-
Ladona, M.G.1
Abildua, R.E.2
Ladero, J.M.3
Roman, J.M.4
Plaza, M.A.5
Agundez, J.A.6
-
9
-
-
0034053367
-
The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients
-
Topic E, Stefanovic M, Ivanisevic AM, Petrinovic R, Curcic I. The cytochrome P450 2D6 (CYP2D6) gene polymorphism among breast and head and neck cancer patients. Clin Chim Acta 2000;296:101-9.
-
(2000)
Clin Chim Acta
, vol.296
, pp. 101-109
-
-
Topic, E.1
Stefanovic, M.2
Ivanisevic, A.M.3
Petrinovic, R.4
Curcic, I.5
-
10
-
-
0031038038
-
Cytochrome P450 2D6 variants in a Caucasian population: Allele frequencies and phenotypic consequences
-
Sachse C, Brockmoller J, Bauer S, Roots I. Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Am J Hum Genet 1997;60:284-95.
-
(1997)
Am J Hum Genet
, vol.60
, pp. 284-295
-
-
Sachse, C.1
Brockmoller, J.2
Bauer, S.3
Roots, I.4
-
11
-
-
0033871198
-
Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR
-
Hersberger M, Marti-Jaun J, Rentsch K, Hanseler E. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin Chem 2000;46:1072-7.
-
(2000)
Clin Chem
, vol.46
, pp. 1072-1077
-
-
Hersberger, M.1
Marti-Jaun, J.2
Rentsch, K.3
Hanseler, E.4
-
12
-
-
0030860004
-
Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: Characterization of 48 mutations and 53 alleles, their frequencies and evolution
-
Marez D, Legrand M, Sabbagh N, Guidice JM, Spire C, Lafitte JJ, et al. Polymorphism of the cytochrome P450 CYP2D6 gene in a European population: characterization of 48 mutations and 53 alleles, their frequencies and evolution. Pharmacogenetics 1997;7:193-202.
-
(1997)
Pharmacogenetics
, vol.7
, pp. 193-202
-
-
Marez, D.1
Legrand, M.2
Sabbagh, N.3
Guidice, J.M.4
Spire, C.5
Lafitte, J.J.6
-
13
-
-
0036089729
-
Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: Allele frequencies and a novel *14B allele in mainland Chinese
-
Ji L, Pan S, Marti-Jaun J, Hanseler E, Rentsch K, Hersberger M. Single-step assays to analyze CYP2D6 gene polymorphisms in Asians: allele frequencies and a novel *14B allele in mainland Chinese. Clin Chem 2002;48:983-8.
-
(2002)
Clin Chem
, vol.48
, pp. 983-988
-
-
Ji, L.1
Pan, S.2
Marti-Jaun, J.3
Hanseler, E.4
Rentsch, K.5
Hersberger, M.6
-
14
-
-
0033965373
-
Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population
-
Garcia-Barcelo M, Chow LY, Chiu HF, Wing YK, Lee DT, Lam KL, et al. Genetic analysis of the CYP2D6 locus in a Hong Kong Chinese population. Clin Chem 2000;46:18-23.
-
(2000)
Clin Chem
, vol.46
, pp. 18-23
-
-
Garcia-Barcelo, M.1
Chow, L.Y.2
Chiu, H.F.3
Wing, Y.K.4
Lee, D.T.5
Lam, K.L.6
-
15
-
-
0027965620
-
Genetic analysis of the Chinese cytochrome P4502D locus: Characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation
-
Johansson I, Oscarson M, Yue QY, Bertilsson L, Sjoqvist F, Ingelman-Sundberg M. Genetic analysis of the Chinese cytochrome P4502D locus: characterization of variant CYP2D6 genes present in subjects with diminished capacity for debrisoquine hydroxylation. Mol Pharmacol 1994;46:452-9.
-
(1994)
Mol Pharmacol
, vol.46
, pp. 452-459
-
-
Johansson, I.1
Oscarson, M.2
Yue, Q.Y.3
Bertilsson, L.4
Sjoqvist, F.5
Ingelman-Sundberg, M.6
-
16
-
-
0027418152
-
Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: Polymorphism in RFLP and DNA sequence of CYP2D6
-
Wang SL, Huang JD, Lai MD, Liu BH, Lai ML. Molecular basis of genetic variation in debrisoquin hydroxylation in Chinese subjects: polymorphism in RFLP and DNA sequence of CYP2D6. Clin Pharmacol Ther 1993;53:410-8.
-
(1993)
Clin Pharmacol Ther
, vol.53
, pp. 410-418
-
-
Wang, S.L.1
Huang, J.D.2
Lai, M.D.3
Liu, B.H.4
Lai, M.L.5
-
17
-
-
0033168038
-
The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome
-
Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, et al. The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome. Cancer Res 1999;59:3180-4.
-
(1999)
Cancer Res
, vol.59
, pp. 3180-3184
-
-
Nilsson, G.1
Skytting, B.2
Xie, Y.3
Brodin, B.4
Perfekt, R.5
Mandahl, N.6
-
18
-
-
0028079647
-
Debrisoquin oxidation genotype and susceptibility to lung cancer
-
Agundez JA, Martinez C, Ladero JM, Ledesma MC, Ramos JM, Martin R, et al. Debrisoquin oxidation genotype and susceptibility to lung cancer. Clin Pharmacol Ther 1994;55:10-4.
-
(1994)
Clin Pharmacol Ther
, vol.55
, pp. 10-14
-
-
Agundez, J.A.1
Martinez, C.2
Ladero, J.M.3
Ledesma, M.C.4
Ramos, J.M.5
Martin, R.6
-
19
-
-
0028957541
-
CYP2D6 genes and risk of liver cancer
-
Agundez JA, Ledesma MC, Benitez J, Ladero JM, Rodriguez-Lescure A, Diaz-Rubio E, et al. CYP2D6 genes and risk of liver cancer. Lancet 1995;345:830-1.
-
(1995)
Lancet
, vol.345
, pp. 830-831
-
-
Agundez, J.A.1
Ledesma, M.C.2
Benitez, J.3
Ladero, J.M.4
Rodriguez-Lescure, A.5
Diaz-Rubio, E.6
-
20
-
-
0026776502
-
Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility
-
Wolf CR, Smith CA, Gough AC, Moss JE, Vallis KA, Howard G, et al. Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis 1992;13:1035-8.
-
(1992)
Carcinogenesis
, vol.13
, pp. 1035-1038
-
-
Wolf, C.R.1
Smith, C.A.2
Gough, A.C.3
Moss, J.E.4
Vallis, K.A.5
Howard, G.6
-
21
-
-
2942598063
-
Cytochrome P450 gene polymorphism and cancer
-
Agundez JA. Cytochrome P450 gene polymorphism and cancer. Curr Drug Metab 2004;5:211-24.
-
(2004)
Curr Drug Metab
, vol.5
, pp. 211-224
-
-
Agundez, J.A.1
-
22
-
-
10744232916
-
Breast carcinoma survival in Europe and the United States
-
Sant M, Allemani C, Berrino F, Coleman MP, Aareleid T, Chaplain G, et al. Breast carcinoma survival in Europe and the United States. Cancer 2004;100:715-22.
-
(2004)
Cancer
, vol.100
, pp. 715-722
-
-
Sant, M.1
Allemani, C.2
Berrino, F.3
Coleman, M.P.4
Aareleid, T.5
Chaplain, G.6
-
23
-
-
0036803355
-
Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer
-
Woo CS, Silberman H, Nakamura SK, Ye W, Sposto R, Colburn W, et al. Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer. Am J Surg 2002;184:337-40.
-
(2002)
Am J Surg
, vol.184
, pp. 337-340
-
-
Woo, C.S.1
Silberman, H.2
Nakamura, S.K.3
Ye, W.4
Sposto, R.5
Colburn, W.6
-
24
-
-
0346602691
-
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine
-
Stearns V, Johnson MD, Rae JM, Morocho A, Novielli A, Bhargava P, et al. Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. J Natl Cancer Inst 2003;95:1758-64.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1758-1764
-
-
Stearns, V.1
Johnson, M.D.2
Rae, J.M.3
Morocho, A.4
Novielli, A.5
Bhargava, P.6
-
25
-
-
0037652178
-
Cytochrome p450 and glutathione transferase expression in human breast cancer
-
El-Rayes BF, Ali S, Heilbrun LK, Lababidi S, Bouwman D, Visscher D, et al. Cytochrome p450 and glutathione transferase expression in human breast cancer. Clin Cancer Res 2003;9:1705-9.
-
(2003)
Clin Cancer Res
, vol.9
, pp. 1705-1709
-
-
El-Rayes, B.F.1
Ali, S.2
Heilbrun, L.K.3
Lababidi, S.4
Bouwman, D.5
Visscher, D.6
-
26
-
-
0346244028
-
A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis
-
Modugno F, Knoll C, Kanbour-Shakir A, Romkes M. A potential role for the estrogen-metabolizing cytochrome P450 enzymes in human breast carcinogenesis. Breast Cancer Res Treat 2003;82:191-7.
-
(2003)
Breast Cancer Res Treat
, vol.82
, pp. 191-197
-
-
Modugno, F.1
Knoll, C.2
Kanbour-Shakir, A.3
Romkes, M.4
|